You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 246 No. 13, September 25, 1981 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 •Correction
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Fetal Risk Associated With Rubella Vaccine

Stephen R. Preblud, MD; Harrison C. Stetler, MD; John A. Frank, Jr, MD; Wayne L. Greaves, MD; Alan R. Hinman, MD; Kenneth L. Herrmann, MD

JAMA. 1981;246(13):1413-1417.


Abstract

Ninety-four susceptible women received either Cendehill or HPV-77 rubella vaccine. All gave birth to healthy infants. Seventeen susceptible women received the RA 27/3 vaccine. All their infants were free of abnormalities compatible with congenital rubella, as were 54 born to mothers of unknown immune status at the time of RA 27/3 vaccination and those later found to be immune. An additional susceptible woman received an unknown strain of vaccine; she also had a healthy infant. The risk of severe congenital malformations after rubella vaccination is low. In our 112 cases, the maximum risk was approximately 3%. Concern about the potential adverse effects of rubella vaccine on the fetus should not interfere with vaccination of women of childbearing age. However, since the actual risk may not be zero, women known to be pregnant should not be vaccinated, and conception should be avoided for three months after vaccination.

(JAMA 1981;246:1413-1417)



Author Affiliations

From the Immunization Division, Center for Prevention Services (Drs Preblud, Stetler, Frank, Greaves, and Hinman), and the Perinatal Virology Branch, Virology Division, Center for Infectious Diseases (Dr Herrmann), US Department of Health and Human Services, Public Health Service, Centers for Disease Control, Atlanta. Dr Preblud is now with The Children's Hospital of Philadelphia. Dr Frank is now with Duke University Medical Center, Durham, NC.


Footnotes

Presented in part at the 20th Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, Sept 23, 1980.

Reprint requests to Centers for Disease Control, 1600 Clifton Rd NE, Atlanta, GA 30333 (Dr Hinman).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Rubella Vaccination during Pregnancy --United States, 1971-1988
JAMA 1989;261:3374-3383.
 

Leads From the MMWR
JAMA 1987;258:751-757.
 

Leads from the MMWR
JAMA 1986;255:2861-2876.
 

Some Current Issues Relating to Rubella Vaccine
Preblud
JAMA 1985;254:253-256.
ABSTRACT  

Rubella Prevention: Recommendation of the Immunization Practices Advisory Committee
ANN INTERN MED 1984;101:505-513.
ABSTRACT  

Leads from the MMWR
JAMA 1983;250:1383-1384.
 

If Nothing Goes Wrong, Is Everything All Right? Interpreting Zero Numerators
Hanley and Lippman-Hand
JAMA 1983;249:1743-1745.
ABSTRACT  

Prevention of Rubella Transmission in Medical Facilities
Greaves et al.
JAMA 1982;248:861-864.
ABSTRACT  

Congenital Rubella Syndrome: A Continuing Problem
Orenstein and Greaves
JAMA 1982;247:1174-1175.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1981 American Medical Association. All Rights Reserved.